{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T20:44:09Z","timestamp":1786826649510,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Basic scientific research Project of Wenzhou","award":["H20210010"],"award-info":[{"award-number":["H20210010"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170061"],"award-info":[{"award-number":["82170061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Circular RNAs (circRNAs), a novel class of non-coding RNAs, play an important regulatory role in pulmonary arterial hypertension (PAH); however, the specific mechanism is rarely studied. In this study, we aimed to discover functional circRNAs and investigate their effects and mechanisms in hypoxia-induced pulmonary vascular remodelling, a core pathological change in PAH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>RNA sequencing was used to illustrate the expression profile of circRNAs in hypoxic PAH. Bioinformatics, Sanger sequencing, and quantitative real-time PCR were used to identify the ring-forming characteristics of RNA and analyse its expression. Then, we established a hypoxia-induced PAH mouse model to evaluate circRNA function in PAH by echocardiography and hemodynamic measurements. Moreover, microRNA target gene database screening, fluorescence in situ hybridisation, luciferase reporter gene detection, and western blotting were used to explore the mechanism of circRNAs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>RNA sequencing identified 432 differentially expressed circRNAs in mouse hypoxic lung tissues. Our results indicated that <jats:italic>circ-Ntrk2<\/jats:italic> is a stable cytoplasmic circRNA derived from <jats:italic>Ntrk2<\/jats:italic> mRNA and frequently upregulated in hypoxic lung tissue. We further found that <jats:italic>circ-Ntrk2<\/jats:italic> sponges <jats:italic>miR-296-5p<\/jats:italic> and <jats:italic>miR-296-5p<\/jats:italic> can bind to the 3\u2032-untranslated region of transforming growth factor-\u03b21 (TGF-\u03b21) mRNA, thereby attenuating TGF-\u03b21 translation. Through gene knockout or exogenous expression, we demonstrated that <jats:italic>circ-Ntrk2<\/jats:italic> could promote PAH and vascular remodelling. Moreover, we verified that <jats:italic>miR-296-5p<\/jats:italic> overexpression alleviated pulmonary vascular remodelling and improved PAH through the TGF-\u03b21\/p38 MAPK pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We identified a new circRNA (<jats:italic>circ-Ntrk2<\/jats:italic>) and explored its function and mechanism in PAH, thereby establishing potential targets for the diagnosis and treatment of PAH. Furthermore, our study contributes to the understanding of circRNA in relation to PAH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-023-02385-7","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T13:03:48Z","timestamp":1678712628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Circ-Ntrk2 acts as a miR-296-5p sponge to activate the TGF-\u03b21\/p38 MAPK pathway and promote pulmonary hypertension and vascular remodelling"],"prefix":"10.1186","volume":"24","author":[{"given":"Lihuang","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shini","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"2385_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5492","volume":"360","author":"T Thenappan","year":"2018","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360: j5492.","journal-title":"BMJ"},{"key":"2385_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chest.2021.08.040","volume":"161","author":"B Lechartier","year":"2022","unstructured":"Lechartier B, Berrebeh N, Huertas A, Humbert M, Guignabert C, Tu L. Phenotypic diversity of vascular smooth muscle cells in pulmonary arterial hypertension: implications for therapy. Chest. 2022;161:219\u201331.","journal-title":"Chest"},{"key":"2385_CR3","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMra2000348","volume":"385","author":"PM Hassoun","year":"2021","unstructured":"Hassoun PM. Pulmonary arterial hypertension. N Engl J Med. 2021;385:2361\u201376.","journal-title":"N Engl J Med"},{"key":"2385_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.2022.4402","volume":"327","author":"NF Ruopp","year":"2022","unstructured":"Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA. 2022;327:1379\u201391.","journal-title":"JAMA"},{"key":"2385_CR5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179:1033\u201355.","journal-title":"Cell"},{"key":"2385_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2015.06.003","volume":"365","author":"S Qu","year":"2015","unstructured":"Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, Sun W, Dou K, Li H. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365:141\u20138.","journal-title":"Cancer Lett"},{"key":"2385_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1126\/science.1238522","volume":"340","author":"JE Wilusz","year":"2013","unstructured":"Wilusz JE, Sharp PA. Molecular biology. A circuitous route to noncoding RNA. Science. 2013;340:440\u20131.","journal-title":"Science"},{"key":"2385_CR8","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1038\/ncomms11215","volume":"7","author":"Q Zheng","year":"2016","unstructured":"Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B, Luo Y, Lyu D, Li Y, Shi G, Liang L, Gu J, He X, Huang S. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016;7:11215.","journal-title":"Nat Commun"},{"key":"2385_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384\u20138.","journal-title":"Nature"},{"key":"2385_CR10","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/cvr\/cvz215","volume":"116","author":"H Li","year":"2020","unstructured":"Li H, Xu J-D, Fang X-H, Zhu J-N, Yang J, Pan R, Yuan S-J, Zeng N, Yang Z-Z, Yang H, Wang X-P, Duan J-Z, Wang S, Luo J-F, Wu S-L, Shan Z-X. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res. 2020;116:1323\u201334.","journal-title":"Cardiovasc Res"},{"key":"2385_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333\u20138.","journal-title":"Nature"},{"key":"2385_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.yjmcc.2016.07.007","volume":"98","author":"S Werfel","year":"2016","unstructured":"Werfel S, Nothjunge S, Schwarzmayr T, Strom T-M, Meitinger T, Engelhardt S. Characterization of circular RNAs in human, mouse and rat hearts. J Mol Cell Cardiol. 2016;98:103\u20137.","journal-title":"J Mol Cell Cardiol"},{"key":"2385_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32:453\u201361.","journal-title":"Nat Biotechnol"},{"key":"2385_CR14","first-page":"984","volume":"18","author":"S Xia","year":"2017","unstructured":"Xia S, Feng J, Lei L, Hu J, Xia L, Wang J, Xiang Y, Liu L, Zhong S, Han L, He C. Comprehensive characterization of tissue-specific circular RNAs in the human and mouse genomes. Brief Bioinform. 2017;18:984\u201392.","journal-title":"Brief Bioinform"},{"key":"2385_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12931-018-0962-1","volume":"20","author":"J Wang","year":"2019","unstructured":"Wang J, Zhu M, Pan J, Chen C, Xia S, Song Y. Circular RNAs: a rising star in respiratory diseases. Respir Res. 2019;20:3.","journal-title":"Respir Res"},{"key":"2385_CR16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.119.13715","volume":"75","author":"J Zhang","year":"2020","unstructured":"Zhang J, Li Y, Qi J, Yu X, Ren H, Zhao X, Xin W, He S, Zheng X, Ma C, Zhang L, Wu B, Zhu D. Circ- calm4 serves as an sponge to regulate Myo10 (Myosin 10) and promote pulmonary artery smooth muscle proliferation. Hypertension. 2020;75:668\u201379.","journal-title":"Hypertension"},{"key":"2385_CR17","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1161\/ATVBAHA.120.315525","volume":"41","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Liu H, Yu H, Zhou Y, Zhang J, Xin W, Li Y, He S, Ma C, Zheng X, Zhang L, Zhao X, Wu B, Jiang C, Zhu D. Circular RNA Calm4 regulates hypoxia-induced pulmonary arterial smooth muscle cells pyroptosis via the Circ-Calm4\/miR-124-3p\/PDCD6 axis. Arterioscler Thromb Vasc Biol. 2021;41:1675\u201393.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2385_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12929-017-0359-3","volume":"24","author":"X Huang","year":"2017","unstructured":"Huang X, Wu P, Huang F, Xu M, Chen M, Huang K, Li G-P, Xu M, Yao D, Wang L. Baicalin attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A receptor-induced SDF-1\/CXCR4\/PI3K\/AKT signaling. J Biomed Sci. 2017;24:52.","journal-title":"J Biomed Sci"},{"key":"2385_CR19","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1164\/rccm.202012-4317SO","volume":"203","author":"BA Maron","year":"2021","unstructured":"Maron BA, Abman SH, Elliott CG, Frantz RP, Hopper RK, Horn EM, Nicolls MR, Shlobin OA, Shah SJ, Kovacs G, Olschewski H, Rosenzweig EB. Pulmonary arterial hypertension: diagnosis, treatment, and novel advances. Am J Respir Crit Care Med. 2021;203:1472\u201387.","journal-title":"Am J Respir Crit Care Med"},{"key":"2385_CR20","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1161\/CIRCRESAHA.121.319969","volume":"130","author":"CJ Rhodes","year":"2022","unstructured":"Rhodes CJ, Sweatt AJ, Maron BA. Harnessing big data to advance treatment and understanding of pulmonary hypertension. Circ Res. 2022;130:1423\u201344.","journal-title":"Circ Res"},{"key":"2385_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2119\/molmed.2013.00165","volume":"20","author":"P Crosswhite","year":"2014","unstructured":"Crosswhite P, Sun Z. Molecular mechanisms of pulmonary arterial remodeling. Mol Med. 2014;20:191\u2013201.","journal-title":"Mol Med"},{"key":"2385_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/ijms17050761","volume":"17","author":"JA Leopold","year":"2016","unstructured":"Leopold JA, Maron BA. Molecular mechanisms of pulmonary vascular remodeling in pulmonary arterial hypertension. Int J Mol Sci. 2016;17:761.","journal-title":"Int J Mol Sci"},{"key":"2385_CR23","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1113\/JP270689","volume":"594","author":"C Veith","year":"2016","unstructured":"Veith C, Schermuly RT, Brandes RP, Weissmann N. Molecular mechanisms of hypoxia-inducible factor-induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension. J Physiol. 2016;594:1167\u201377.","journal-title":"J Physiol"},{"key":"2385_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.molmed.2018.01.005","volume":"24","author":"F Cheng","year":"2018","unstructured":"Cheng F, Loscalzo J. Pulmonary comorbidity in lung cancer. Trends Mol Med. 2018;24:239\u201341.","journal-title":"Trends Mol Med"},{"key":"2385_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.yjmcc.2007.09.006","volume":"44","author":"SY Chan","year":"2008","unstructured":"Chan SY, Loscalzo J. Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol. 2008;44:14\u201330.","journal-title":"J Mol Cell Cardiol"},{"key":"2385_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1378\/chest.10-1166","volume":"140","author":"LM Brown","year":"2011","unstructured":"Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest. 2011;140:19\u201326.","journal-title":"Chest"},{"key":"2385_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1165\/rcmb.2014-0166TR","volume":"52","author":"G Zhou","year":"2015","unstructured":"Zhou G, Chen T, Raj JU. MicroRNAs in pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2015;52:139\u201351.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2385_CR28","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/biom12060796","volume":"12","author":"L Deng","year":"2022","unstructured":"Deng L, Han X, Wang Z, Nie X, Bian J. The landscape of noncoding RNA in pulmonary hypertension. Biomolecules. 2022;12:796.","journal-title":"Biomolecules"},{"key":"2385_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"L-L Chen","year":"2020","unstructured":"Chen L-L. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2385_CR30","doi-asserted-by":"publisher","first-page":"2200012","DOI":"10.1183\/13993003.00012-2022","volume":"60","author":"MK Ali","year":"2022","unstructured":"Ali MK, Schimmel K, Zhao L, Chen C-K, Dua K, Nicolls MR, Spiekerkoetter E. The role of circular RNAs in pulmonary hypertension. Eur Respir J. 2022;60:2200012.","journal-title":"Eur Respir J"},{"key":"2385_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1164\/rccm.202108-1868LE","volume":"205","author":"X Sun","year":"2022","unstructured":"Sun X, Chen R, Yao X, Zheng Z, Wang C, Chen J, Cheng J. circGSAP: a new clinical biomarker for idiopathic pulmonary hypertension? Am J Respir Crit Care Med. 2022;205:252\u20133.","journal-title":"Am J Respir Crit Care Med"},{"key":"2385_CR32","first-page":"1353","volume":"42","author":"J Wang","year":"2018","unstructured":"Wang J, Zhu M-C, Kalionis B, Wu J-Z, Wang L-L, Ge H-Y, Chen C-C, Tang X-D, Song Y-L, He H, Xia S-J. Characteristics of circular RNA expression in lung tissues from mice with hypoxia-induced pulmonary hypertension. Int J Mol Med. 2018;42:1353\u201366.","journal-title":"Int J Mol Med"},{"key":"2385_CR33","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1164\/rccm.202005-2052LE","volume":"203","author":"P Yuan","year":"2021","unstructured":"Yuan P, Wu W-H, Gong S-G, Jiang R, Zhao Q-H, Pudasaini B, Sun Y-Y, Li J-L, Liu J-M, Wang L. Impact of circGSAP in peripheral blood mononuclear cells on idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2021;203:1579\u201383.","journal-title":"Am J Respir Crit Care Med"},{"key":"2385_CR34","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391.","journal-title":"Nat Rev Genet"},{"key":"2385_CR35","doi-asserted-by":"crossref","unstructured":"Lu G-F, Geng F, Deng L-P, Lin D-C, Huang Y-Z, Lai S-M, Lin Y-C, Gui L-X, Sham JSK, Lin M-J. Reduced CircSMOC1 level promotes metabolic reprogramming via PTBP1 (Polypyrimidine Tract-Binding Protein) and miR-329\u20133p in pulmonary arterial hypertension rats. Hypertension. 2022:101161HYPERTENSIONAHA12219183.","DOI":"10.1161\/HYPERTENSIONAHA.122.19183"},{"key":"2385_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024147","volume":"11","author":"C-X Huang","year":"2022","unstructured":"Huang C-X, Jiang Z-X, Du D-Y, Zhang Z-M, Liu Y, Li Y-T. Hsa_circ_0016070\/micro-340-5p axis accelerates pulmonary arterial hypertension progression by upregulating TWIST1 transcription via TCF4\/\u03b2-catenin complex. J Am Heart Assoc. 2022;11: e024147.","journal-title":"J Am Heart Assoc"},{"key":"2385_CR37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/onc.2012.637","volume":"33","author":"T Li","year":"2014","unstructured":"Li T, Lu YY, Zhao XD, Guo HQ, Liu CH, Li H, Zhou L, Han YN, Wu KC, Nie YZ, Shi YQ, Fan DM. MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1. Oncogene. 2014;33:783\u201393.","journal-title":"Oncogene"},{"key":"2385_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-019-0958-6","volume":"18","author":"D Rong","year":"2019","unstructured":"Rong D, Lu C, Zhang B, Fu K, Zhao S, Tang W, Cao H. CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p. Mol Cancer. 2019;18:25.","journal-title":"Mol Cancer"},{"key":"2385_CR39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13046-018-0957-2","volume":"37","author":"D-M Shi","year":"2018","unstructured":"Shi D-M, Li L-X, Bian X-Y, Shi X-J, Lu L-L, Zhou H-X, Pan T-J, Zhou J, Fan J, Wu W-Z. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1\/ERBB2\/ERBB3 signaling. J Exp Clin Cancer Res. 2018;37:294.","journal-title":"J Exp Clin Cancer Res"},{"key":"2385_CR40","doi-asserted-by":"publisher","first-page":"2002341","DOI":"10.1183\/13993003.02341-2020","volume":"57","author":"C Guignabert","year":"2021","unstructured":"Guignabert C, Humbert M. Targeting transforming growth factor-\u03b2 receptors in pulmonary hypertension. Eur Respir J. 2021;57:2002341.","journal-title":"Eur Respir J"},{"key":"2385_CR41","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.108.821504","volume":"119","author":"L Long","year":"2009","unstructured":"Long L, Crosby A, Yang X, Southwood M, Upton PD, Kim D-K, Morrell NW. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation. 2009;119:566\u201376.","journal-title":"Circulation"},{"key":"2385_CR42","doi-asserted-by":"publisher","first-page":"L604","DOI":"10.1152\/ajplung.00309.2011","volume":"302","author":"RJ Davies","year":"2012","unstructured":"Davies RJ, Holmes AM, Deighton J, Long L, Yang X, Barker L, Walker C, Budd DC, Upton PD, Morrell NW. BMP type II receptor deficiency confers resistance to growth inhibition by TGF-\u03b2 in pulmonary artery smooth muscle cells: role of proinflammatory cytokines. Am J Physiol Lung Cell Mol Physiol. 2012;302:L604\u201315.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2385_CR43","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.3390\/ijms19102957","volume":"19","author":"TV Kudryashova","year":"2018","unstructured":"Kudryashova TV, Shen Y, Pena A, Cronin E, Okorie E, Goncharov DA, Goncharova EA. Inhibitory antibodies against activin A and TGF-\u03b2 reduce self-supported, but not soluble factors-induced growth of human pulmonary arterial vascular smooth muscle cells in pulmonary arterial hypertension. Int J Mol Sci. 2018;19:2957.","journal-title":"Int J Mol Sci"},{"key":"2385_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0068-3","volume":"50","author":"Z Cai","year":"2018","unstructured":"Cai Z, Li J, Zhuang Q, Zhang X, Yuan A, Shen L, Kang K, Qu B, Tang Y, Pu J, Gou D, Shen J. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-\u03b21 and IL-6\/STAT3 signaling pathways. Exp Mol Med. 2018;50:1.","journal-title":"Exp Mol Med"},{"key":"2385_CR45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1165\/rcmb.2016-0374OC","volume":"57","author":"B Kojonazarov","year":"2017","unstructured":"Kojonazarov B, Novoyatleva T, Boehm M, Happe C, Sibinska Z, Tian X, Sajjad A, Luitel H, Kriechling P, Posern G, Evans SM, Grimminger F, Ghofrani HA, Weissmann N, Bogaard HJ, Seeger W, Schermuly RT. p38 MAPK inhibition improves heart function in pressure-loaded right ventricular hypertrophy. Am J Respir Cell Mol Biol. 2017;57:603\u201314.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2385_CR46","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1165\/rcmb.2017-0197ED","volume":"57","author":"RR Vanderpool","year":"2017","unstructured":"Vanderpool RR, Tang H, Rischard F, Yuan JXJ. Is p38 MAPK a dark force in right ventricular hypertrophy and failure in pulmonary arterial hypertension? Am J Respir Cell Mol Biol. 2017;57:506\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2385_CR47","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/cvr\/cvx051","volume":"113","author":"D Jia","year":"2017","unstructured":"Jia D, He Y, Zhu Q, Liu H, Zuo C, Chen G, Yu Y, Lu A. RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension. Cardiovasc Res. 2017;113:586\u201397.","journal-title":"Cardiovasc Res"},{"key":"2385_CR48","doi-asserted-by":"publisher","first-page":"L919","DOI":"10.1152\/ajplung.00012.2004","volume":"287","author":"KKK Sheares","year":"2004","unstructured":"Sheares KKK, Jeffery TK, Long L, Yang X, Morrell NW. Differential effects of TGF-beta1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2004;287:L919\u201327.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2385_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jcp.24443","volume":"229","author":"L Zhang","year":"2014","unstructured":"Zhang L, Li Y, Chen M, Su X, Yi D, Lu P, Zhu D. 15-LO\/15-HETE mediated vascular adventitia fibrosis via p38 MAPK-dependent TGF-\u03b2. J Cell Physiol. 2014;229:245\u201357.","journal-title":"J Cell Physiol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-023-02385-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T13:06:50Z","timestamp":1678712810000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-023-02385-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2385"],"URL":"https:\/\/doi.org\/10.1186\/s12931-023-02385-7","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Animal Ethics Committee of Wenzhou Medical University (wydw2021-0257). All animal experiments complied with the ARRIVE guidelines and were conducted in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010\/63\/EU for animal experiments, or the National Research Council's Guide for the Care and Use of Laboratory Animals. All animals were executed using anaesthesia with CO<sub>2<\/sub> and sacrificed at the end of study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}